Antibiotic resistance and vaccination in patients with urinary tract infection
Journal Title: Нирки - Year 2018, Vol 7, Issue 1
Abstract
Limited in experience of using uroantiseptics, even those manufactured in European countries, such as Furamag and Macmiror, excessive use of antibiotics, which causes antibiotic resistance in the EU countries and form resistance to antibiotics. The problem of treatment resistant, recurrent infections of the urinary tract and asymptomatic bacteriuria can be solved with vaccinotherapy. Urivac may recommend as an independent option or in combination with prophylactic treatment with uroanticeptic and/or phytomedicine.
Authors and Affiliations
D. D. Ivanov
Keywords
Related Articles
- EP ID EP265050
- DOI 10.22141/2307-1257.7.1.2018.122213
- Views 69
- Downloads 0
Influence of Aflazin® on the Adhesive Properties of Microorganisms — Pathogens of Catheter-Related Infections
The influence of Aflazin® (UTIRose™) and separately its combination with levofloxacin on the adhesive properties of opportunistic pathogens has been studied. It is found that addition of the active substance of Aflazin®...
The Experience of Combination Phytotherapy in Patients with Urethrolithiasis
In the article the attention was paid to one of the most urgent problems of modern medicine — urolithiasis. One component of the pharmacotherapy of this disease is phytotherapy. This article provides an experience of use...
Infections of Urinary Tract in Children: 2012 Updating
.
Effective treatment and prevention of recurrent urinary tract infections by using Cysto-aurin®, a Solidago virgaurea preparation
We conducted a study of clinical and laboratory efficacy, as well as evaluated the effect on the quality of life of intermittent therapy with Cysto-aurin drug in 96 patients with recurrent urinary tract infection (UTI)....
Protein Klotho and FGF23 fibroblasts growth factor as markers of chronic renal disease
Chronic kidney disease (CKD) is a global public health problem in the world. Research scientists are aimed at finding new biomarkers for CKD. Such biomarkers are α-Klotho soluble protein and fibroblast growth factor (FGF...